A carregar...
Relative Tolerability of Alzheimer's Disease Treatments
OBJECTIVE: In the US, approved therapies for mild to moderate Alzheimer's disease (AD) currently comprise three cholinesterase inhibitors (ChEIS: donepezil, galantamine, and rivastigmine), while the N-methyl-D-aspartate (NMDA) receptor antagonist memantine and the ChEI donepezil are approved fo...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Matrix Medical Communications
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695725/ https://ncbi.nlm.nih.gov/pubmed/19724715 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|